ARTICLES — COMMENTARIES

SORT date author clear filters


Show


Hróbjartsson A, Gøtzsche PC, Gluud C (1988).
The controlled clinical trial turns 100 years: Fibiger’s trial of serum treatment of diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Loudon I (2002).
The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P (2002).
Randomisation and alternation: a note on Diehl et al. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Olsen SF (2002).
The People’s League of Health trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I, Clarke M (2002).
J Guy Scadding and the move from alternation to randomization. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
John Clark 1780 & 1792: learning from properly kept records. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
Withering’s 1785 appeal for caution when reporting on a new medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
James Lind and scurvy: 1747 to 1795. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pollock JI (2003).
A controlled trial using a factorial design reported in 1946. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2003).
The contribution of William Fletcher’s 1907 report to finding a cause and cure for beriberi. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Doll R (2003).
Controlled trials testing two or more treatments simultaneously. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
James Lind and the evaluation of clinical practice. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gong Y, Gluud C (2003).
Commentary on the Ben Cao Tu Jing (11th century). Atlas of Materia Medica. Song Dynasty (960-1279). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
Edward Alanson 1782: responsibility in surgical innovation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Senn SJ (2003).
Cushny and Peebles and optical isomers, 1905. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2003).
Thalidomide: an unanticipated adverse effect. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
MacLean 1818: comparing like with like and recognising ethical double standards in therapeutic experimentation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2003).
James Lind at Haslar Hospital 1758-1774: a methodological theorist. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2003).
‘An innocent deception’: placebo controls in the St Petersburg homeopathy trial, 1829-30. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2003).
Aspirin: an unanticipated beneficial effect. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Weingarten S (2003).
Food in Daniel 1:1-16: the first controlled experiment? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2004).
Pierre-Charles-Alexandre Louis and the evaluation of bloodletting. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cochrane AL, Blythe M (2004).
Sickness in Salonica. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Houston C (2004).
Ferguson’s BCG research – Canada’s first randomized clinical trial? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Clarke M (2004).
The 1944 patulin trial of the British Medical Research Council: an example of how concerted common purpose can get reliable answers to important questions very quickly. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stoll S (2004).
Paul Martini’s Methodology of therapeutic investigation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Diaz M, Neuhauser D (2004).
Lessons from using randomization to assess gold treatment for tuberculosis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Hampton J (2004).
An early parallel group trial in cardiology. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Lee MR (2004).
The miracle of St. Alfege’s: discovering a treatment for myaesthenia gravis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Klar N, Donner A (2004).
The impact of E.F. Lindquist’s text “Statistical Analysis in Educational Research” on cluster randomisation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gøtzsche PC (2004).
Niels Finsen’s treatment for lupus vulgaris. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Kaptchuk TJ (2004).
Early use of blind assessment in a homeopathic scientific experiment. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Elwood P (2004).
The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bastian H (2004).
Down and almost out in Scotland: George Orwell, tuberculosis and getting streptomycin in 1948. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sutton G (2004).
James Lind aboard Salisbury. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2004).
Ambroise Paré’s accounts of new methods for treating gunshot wounds and burns. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2005).
Quantitative evidence for judgments on the efficacy of inoculation for the prevention of smallpox: England and New England in the 1700s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Spanager L (2005).
Jansen’s 1910 use of a single blind experiment to assess the effects of radioactive water on rheumatic diseases. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pollock JI (2005).
Two controlled trials of supplementary feeding of British school children in the 1920s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Hemminki E (2005).
Commentary on an early placebo controlled trial in Finland. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tibi S (2005).
Al-Razi and Islamic medicine in the 9th Century. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Volmink J (2005).
The willow as a Hottentot (Khoikhoi) remedy for rheumatic fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2005).
Mesmer’s 1780 proposal for a controlled trial to test his method of treatment using ‘Animal Magnetism’. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

McPherson K, Bunker JP (2006).
Costs, risks and benefits of surgery: a milestone in the development of health services research. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marks HM† (2006).
The Kendrick-Eldering-(Frost) pertussis vaccine field trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jefferson T (2006).
Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nasser M, Tibi A (2006).
Ibn Hindu and the science of medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Davey Smith G (2006).
Capitalising on Mendelian randomization to assess the effects of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2006).
Transatlantic ideas on the philosophy of therapeutics in the middle of the 19th century. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stolberg M (2006).
Inventing the randomized double-blind trial: The Nürnberg salt test of 1835. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2006).
Jules Gavarret’s Principes Généraux de Statistique Médicale: a pioneering text on the statistical analysis of the results of treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2006).
Joseph Goldberger’s research on the prevention of pellagra. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2007).
Claude Bernard, statistics, and comparative trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Neuhauser D, Diaz M, Chalmers I (2007).
A puzzling omission in a great medical textbook edited by a pioneer of controlled trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Louis-Courvoisier M (2007).
An 18th century controlled trial prompted by a potential shortage of hospital beds. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sinclair L (2007).
Recognising, treating and understanding pernicious anaemia. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marks HM† (2007).
James Angus Doull and the well-controlled common cold. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2007).
An early 18th century proposal for improving medicine by tabulating and analysing practice. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Kerr CE, Milne I, Kaptchuk TJ (2007).
William Cullen and a missing mind-body link in the early history of placebos. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nasser M, Tibi A, Savage-Smith E (2007).
Ibn Sina’s Canon of Medicine: 11th century rules for assessing the effects of drugs. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Neuhauser D, Diaz M (2007).
Use of rotation to allocate patients to homeopathic or regular medical services in Cook County Hospital, Chicago, 1882. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Joosse NP, Pormann PE (2008).
Archery, mathematics, and conceptualising inaccuracies in medicine in 13th century Iraq and Syria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bracken MB (2008).
Why animal studies are often poor predictors of human reactions to exposure. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Podolsky SH (2008).
Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nunn JF (2008).
A treatment that has stood the test of time for over three and a half millennia. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gluud C, Hilden J (2008).
Povl Heiberg’s 1897 methodological study on the statistical method as an aid in therapeutic trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW, Williams AE (2008).
Zabdiel Boylston’s evaluation of inoculation against smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Huth EJ (2008).
The move toward setting scientific standards for the content of medical review articles. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stylianou C, Kelnar C (2008).
The introduction of successful treatment of diabetes mellitus with insulin. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Middleton J (2008).
Pellagra and the blues song ‘Cornbread, meat and black molasses’. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Shannon H (2008).
A statistical note on Karl Pearson’s 1904 meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2008).
William Watson’s use of controlled clinical experiments in 1768. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2009).
Comparative evaluation of homeopathy and allopathy within the Parisian hospital system, 1849-51. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Rennie D, Chalmers I (2009).
Exposing the dangers to patients of medical reviews and textbooks that ignore scientific principles. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Williams KJ (2009).
The introduction of ‘chemotherapy’ using arsphenamine – the first magic bullet. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Thacker SB (2009).
How I came to write papers for clinicians in the late 1980s about improving the quality of reviews. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I, Toth B (2009).
19th century controlled trials to test whether belladonna prevents scarlet fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Adams CE (2009).
James Crichton Browne and controlled evaluation of drug treatment for mental illness. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Moore W (2009).
John Hunter: learning from natural experiments, ‘placebos’, and the state of mind of a patient in the 18th century. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cox DR (2009).
Randomization for concealment. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Wessely S (2009).
Surgery for the treatment of psychiatric illness: the need to test untested theories. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Hytten F (2009).
Isabella Leitch’s contributions to the development of systematic reviews of research evidence. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Furberg CD (2009).
How should one analyse and interpret clinical trials in which patients don’t take the treatments assigned to them? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P (2009).
A statistical note on the analysis of the 1948 MRC streptomycin trial. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Löwy I (2010).
Martin Arrowsmith’s clinical trial: scientific precision and heroic medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2010).
Joseph Asbury Bell and the birth of randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Morabia A (2010).
Edward Jenner’s 1798 report of challenge experiments demonstrating the protective effects of cowpox against smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

JLL Bulletin Editors (2010).
Commentary on Rapport général sur les prix décernés en 1862. Mémoires de l’Académie Impériale de Médecine XXVI, Paris: Ballière, p xxii-xxxv. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2010).
Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Towards endocrinology: Theodor Kocher’s 1883 account of the unexpected effects of total ablation of the thyroid. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2010).
Thomas Nettleton and the dawn of quantitative assessments of the effects of medical interventions. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Adolf Bingel’s blinded, controlled comparison of different anti-diphtheritic sera in 1918. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Edwards M (2010).
Dora Colebrook and the evaluation of light therapy. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gluud C (2010).
Danish contributions to the evaluation of serum therapy for diphtheria in the 1890s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bryder L (2010).
The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a ‘scientific’ approach. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Farewell V, Johnson A (2010).
The first British textbook of medical statistics. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Slater SD (2010).
The discovery of thyroid replacement therapy. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Opinel A, Gachelin G (2010).
French 19th century contributions to the development of treatments for diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Spain P, Kadan-Lottick N (2010).
Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cook H (2010).
Testing the effects of Jesuit’s bark in the Chinese Emperor’s court. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Doyle D (2011).
Thomas MacLagan’s 1876 demonstration of the dramatic effects of salicin in rheumatic fever. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Maehle A-H (2011).
Four early clinical studies to assess the effects of Peruvian bark. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Podolsky SH, Davey Smith G (2011).
Park’s story and Winters’ tale: alternate allocation clinical trials in turn of the Century America. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Ferroni E, Jefferson T, Gachelin G (2011).
Angelo Celli and research on the prevention of malaria in Italy a century ago. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2011).
Observation and experimentation in developing ‘the Suttonian Method’ of inoculation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Wickenden JVS (2011).
The strange disappearances of James Lind. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Solis C (2011).
Bartolomé Hidalgo de Agüero’s 16th century, evidence-based challenge to the orthodox management of wounds. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Fox DM (2011).
Systematic reviews and health policy: the influence of a project on perinatal care since 1988. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Birbeck E (2011).
The Royal Hospital Haslar: from Lind to the 21st century. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I, Dukan E, Podolsky SH, Davey Smith G (2011).
The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gartlehner G, Stepper K (2011).
Julius Wagner-Jauregg: pyrotherapy, Simultanmethode, and ‘racial hygiene’. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Farewell V, Johnson A (2011).
The origins of Austin Bradford Hill’s classic textbook of medical statistics. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Mann H, Djulbegovic B (2012).
Comparator bias: why comparisons must address genuine uncertainties. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2012).
Adolphe Vorderman’s 1897 study on beriberi: an example of scrupulous efforts to avoid bias. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Cockerill A, Goble PJ (2012).
Thomas Graham Balfour, pioneering medical statistician and stern disciplinarian. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Campbell MJ (2012).
Doing clinical trials large enough to achieve adequate reductions in uncertainties about treatment effects. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tsiompanou E, Marketos SG† (2012).
Hippocrates: timeless still. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Marušić A, Fatović-Ferenčić S (2012).
Adoption of the double dummy trial design to reduce observer bias in testing treatments. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sidebottom E (2012).
Roger Bacon and the beginnings of experimental science in Britain. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2012).
The origins of vaccination: no inoculation, no vaccination. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2012).
John Haygarth’s 18th century ‘Rules of Prevention’ for eradicating smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Boylston AW (2012).
The origins of inoculation. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2013).
Francis Bacon’s comments on the power of negative observations in his Novum Organum, first published in 1620. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Loudon I (2013).
Ignaz Phillip Semmelweis’ studies of death in childbirth. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

La Rochelle P, Julien A-S (2013).
How dramatic were the effects of handwashing on maternal mortality observed by Ignaz Semmelweis? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Pormann PE (2013).
Qualifying and quantifying medical uncertainty in 10th century Baghdad: Abu Bakr al-Razi. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Gachelin G (2013).
The interaction of scientific evidence and politics in debates about preventing malaria in 1925. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Chalmers I (2013).
UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2013).
William Cheselden’s 1740 presentation of data on age-specific mortality after lithotomy. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Sugiyama Y, Seita A (2013).
Kanehiro Takaki and the control of beriberi in the Japanese Navy. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bryder L (2014).
The Medical Research Council and treatments for tuberculosis before streptomycin. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2014).
The mustard gas experiments done by the British Homoeopathic Society for the Ministry of Home Security, 1941-42. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Oliver S (2014).
Advantages of concurrent preparation and reporting of systematic reviews of quantitative and qualitative evidence. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Milne I, Chalmers I (2014).
Alexander Lesassier Hamilton’s 1816 report of a controlled trial of bloodletting. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Bird SM (2014).
The 1959 meeting in Vienna on controlled clinical trials – a methodological landmark. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2014).
Statistics and the British controversy about the effects of Joseph Lister’s system of antisepsis for surgery, 1867-1890. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Hampton J (2015).
Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Moberg J, Kramer M (2015).
A brief history of the cluster randomized trial design. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Straus S, Eisinga A, Sackett D† (2015).
What drove the Evidence Cart? Bringing the library to the bedside. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Toth B (2015).
Why the MRC Therapeutic Trials Committee didn’t introduce controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Schlesselman JJ (2015).
Jerome Cornfield’s Bayesian approach to assessing interim results in clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Wager E (2015).
Good Publication Practice 3: reflections on becoming a guideline grandmother. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Dean ME (2015).
Selective suppression by the medical establishment of unwelcome research findings: The cholera treatment evaluation by the General Board of Health, London 1854. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Burton MJ (2015).
Astley Cooper’s dramatically effective treatment of deafness. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
Petrarch’s letter to Boccaccio ‘on the proud and presumptuous behaviour of physicians’. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Howick J (2016).
Aulus Cornelius Celsus and ‘empirical’ and ‘dogmatic’ medicine JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
George Starkey’s 1658 challenge to Galenists to compare their treatment results with his. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
Joan Baptista van Helmont’s proposal around 1643 for a randomised comparison of using or withholding bloodletting and purging when treating fevers. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Peto J (2016).
Reflections on the importance of strict adherence to treatment protocols: acute lymphoblastic leukaemia in children in the 1970s in the US and the UK. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Peto R (2016).
Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Donaldson IML (2016).
Antoine de Lavoisier’s role in designing a single-blind trial to assess whether ‘Animal Magnetism’ exists. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Zwarenstein M (2016).
‘Pragmatic’ and ‘Explanatory’ attitudes to randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Lechuga RI, Castro AC (2016).
Dramatic effects of control measures on deaths from yellow fever in Havana, Cuba, in the early 1900’s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View